Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:1035-1041

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorin, E.
Right arrow Articles by Dupuis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorin, E.
Right arrow Articles by Dupuis, J.

(Hypertension. 1998;31:1035-1041.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Endothelin-1 Regulates Tone of Isolated Small Arteries in the Rat

Effect of Hyperendothelinemia

Eric Thorin; Peter Cernacek; ; Jocelyn Dupuis

From the Institut de Cardiologie de Montréal, Centre de Recherche (E.T., J.D.), and the Royal Victoria Hospital, Division of Clinical Biochemistry (P.C.), Montréal, Canada.

Correspondence to Eric Thorin, PhD, Institut de Cardiologie de Montréal, Centre de Recherche, 5000 rue Bélanger Est, Montréal (Qc) H1T 1C8, Canada. E-mail thorin{at}icm.umontreal.ca

Abstract—Chronic elevation of plasma endothelin-1 (ET-1) levels has been reported in several pathological conditions. To investigate the consequences of increased circulating ET-1 on vascular responsiveness, Sprague-Dawley rats (n=16) were chronically instrumented with a minipump delivering ET-1 at a constant dose for 7 days. Plasma ET-1 levels were more than doubled in treated (0.98±0.09 pmol/L; P<.05) versus untreated sham-operated rats (0.43±0.04 pmol/L), whereas systolic arterial blood pressure increased (139±5 versus 128±4 mm Hg in untreated rats; P<.05). After rats were killed, segments of middle cerebral (MCA) and mesenteric (MES) arteries were mounted on an isometric myograph. ET-induced contraction was shifted to the right in ET-1–treated animals and not modified by BQ123 (an ETA receptor antagonist); bosentan (ETA/B receptor antagonist) prevented ET-1–induced contraction in both groups. After inhibition of nitric oxide synthase with N{omega}-nitro-L-arginine (L-NNA), both phenylephrine and oxymetazoline (an {alpha}2-adrenoceptor agonist) induced MCA contraction. The sensitivity to phenylephrine was decreased in ET-1–treated compared with control rats (P<.05). Sensitivity to phenylephrine-induced contraction was decreased by BQ123 in control rats only. In contrast, L-NNA revealed greater oxymetazoline-induced contractions in treated compared with control MCA rings (P<.05); this potentiation was blunted by bosentan but unaffected by BQ123. Removal of the endothelium revealed a direct constrictor effect of oxymetazoline that was insensitive to L-NNA alone or combined with bosentan; however, oxymetazoline induced significantly lower constriction in treated rat MCA segments. Responses to oxymetazoline were also blunted in treated compared with untreated denuded MES arteries. In conclusion, chronic elevated plasmatic ET-1 decreases smooth muscle cell sensitivity to contractile agonists both in MCA and MES rings. In cerebral vessels, endothelial {alpha}2-adrenoceptor–dependent stimulation induced greater contractile responses in treated rats which were sensitive to bosentan, suggesting that oxymetazoline stimulates ET-1 release from the endothelium. This may represent a compensatory mechanism for the loss of smooth muscle sensitivity.


Key Words: mesenteric arteries • cerebral arteries • adrenergic antagonists • endothelin • rats




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Migneault, S. Sauvageau, L. Villeneuve, E. Thorin, A. Fournier, N. Leblanc, and J. Dupuis
Chronically Elevated Endothelin Levels Reduce Pulmonary Vascular Reactivity to Nitric Oxide
Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 506 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. D. Bukoski, S. Shearin, W. F. Jackson, and M. F. Pamarthi
Inhibition of Ca2+-Induced Relaxation by Oxidized Tungsten Wires and Paratungstate
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 343 - 350.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Gilbert, J. Tremblay, and E. Thorin
Endothelium-Derived Endothelin-1 Reduces Cerebral Artery Sensitivity to Nitric Oxide by a Protein Kinase C-Independent Pathway
Stroke, October 1, 2001; 32(10): 2351 - 2355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Thorin, M. Lucas, P. Cernacek, and J. Dupuis
Role of ETA receptors in the regulation of vascular reactivity in rats with congestive heart failure
Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H844 - H851.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Henrion, M. Iglarz, and B. I. Levy
Chronic Endothelin-1 Improves Nitric Oxide–Dependent Flow-Induced Dilation in Resistance Arteries From Normotensive and Hypertensive Rats
Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2148 - 2153.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T.-D. Nguyen, P. Vequaud, and E. Thorin
Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and {alpha}-adrenergic-dependent contractions of rabbit resistance arteries
Cardiovasc Res, August 15, 1999; 43(3): 755 - 761.
[Abstract] [Full Text] [PDF]